These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Andrographolide sulfonate ameliorates experimental colitis in mice by inhibiting Th1/Th17 response. Liu W, Guo W, Guo L, Gu Y, Cai P, Xie N, Yang X, Shu Y, Wu X, Sun Y, Xu Q. Int Immunopharmacol; 2014 Jun; 20(2):337-45. PubMed ID: 24704625 [Abstract] [Full Text] [Related]
3. A natural flavonoid glucoside icariin inhibits Th1 and Th17 cell differentiation and ameliorates experimental autoimmune encephalomyelitis. Shen R, Deng W, Li C, Zeng G. Int Immunopharmacol; 2015 Feb; 24(2):224-231. PubMed ID: 25528476 [Abstract] [Full Text] [Related]
12. Endogenous regulation of visceral pain via production of opioids by colitogenic CD4(+) T cells in mice. Boué J, Basso L, Cenac N, Blanpied C, Rolli-Derkinderen M, Neunlist M, Vergnolle N, Dietrich G. Gastroenterology; 2014 Jan; 146(1):166-75. PubMed ID: 24055279 [Abstract] [Full Text] [Related]
13. Critical role of ROCK2 activity in facilitating mucosal CD4+ T cell activation in inflammatory bowel disease. Yang W, Zhou G, Yu T, Chen L, Yu L, Guo Y, Cong Y, Liu Z. J Autoimmun; 2018 May; 89():125-138. PubMed ID: 29269245 [Abstract] [Full Text] [Related]
18. Arctigenin exerts anti-colitis efficacy through inhibiting the differentiation of Th1 and Th17 cells via an mTORC1-dependent pathway. Wu X, Dou Y, Yang Y, Bian D, Luo J, Tong B, Xia Y, Dai Y. Biochem Pharmacol; 2015 Aug 15; 96(4):323-36. PubMed ID: 26074264 [Abstract] [Full Text] [Related]